
|Articles|January 10, 2005
New drug treats overactive bladder without drying mouth
Overactive bladder (OAB) affects approximately 17 million to 20 million people in the United States, yet few realize that it is a treatable condition. Many people believe that it is a natural part of the aging process and are embarrassed to discuss it. It is estimated that costs related to OAB were nearly $14 billion in this country in 2000, similar to that of gynecological and breast cancers, osteoporosis, or arthritis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Retatrutide Delivers Weight Loss, A1C Improvements in Additional Trials
2
FDA Approves First-in-Class Centanafadine for Treatment of ADHD
3
FDA Approves First Fixed-Dose OTC of Acetaminophen and Naproxen
4
FAQ: Navigating the Use of Diabetes Technology
5

























